USCACA hosted a symposium in the 7th Chinese Conference on Oncology (CCO)

Beijing, September 8. Invited by Chinese Anti-Cancer Association, USCACA hosted a special symposium on Collaboration between US and China in Cancer Research. Drs. Wei Zhou and Wancai Yang chaired the symposium. Six experts from US and China (Yunguang Tong, Shi-Yuan Cheng, Zhimin Lv, Wancai Yang, Biao He and Jianmin Fang) introduced their own research and shared experience in a series of topics, including scientific training and career development in US, the difference of research environment, and traps in international collaboration. Drs. Wei Zhang and Shujuan Ba attended the symposium and issued the AFCR-USCACA Scholarships Award to five highly talented young scientists.

A complete list of presentations for the symposium
1. PTTG1 regulates anti-cancer drug response in colorectal cancer, Yunguang Tong, University of California, Los Angeles
2. Signaling Cascades that Mediate PDGFR alpha-driven Glioblastoma Tumorigenesis and Invasion, Shi-Yuan Cheng , Northwestern University, Chicago, US
3. The Warburg effect and beyond, Zhimin Lv, MD Anderson Cancer Center, USA
4. A novel single nucleotide polymorphism of the phospholipase C epsilon 1 in esophagitis and esophageal cancer, Wancai Yang, Xinxiang Medical University
5. Targeting stem cell pathways in human lung cancer, Biao He, University of California, San Francisco, USA
6. How does tumor escape from anti-VEGF therapy, Jianming Fang, Tongji University